Premise, promise, and potential limitations of invasive devices to treat hypertension

Current Cardiology Reports

Volumn 13, Issue 1, 2011, Pages 86-92

  Martin, Elizabeth A ^a   Victor, Ronald G ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Afferent renal nerves; Antihypertensive therapies; Blood flow; Blood pressure; Carotid baroreceptor pacemaker; Denervation; Efferent renal nerves; Electrical stimulation; Heart failure; Heart rate; Hypertension; Innervation; Kidney disease; Left ventricular dysfunction; Norepinephrine; Parasympathetic nervous system; Radiofrequency catheter ablation; Renal disease; Renal vasoconstriction; Renin; Sodium; Sympathetic nervous system; Sympathetic overactivity; Vascular resistance

Indexed keywords

ADENOSINE; ANTIHYPERTENSIVE AGENT; UREA;

ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CAROTID SINUS; CAROTID SINUS PRESSORECEPTOR; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CONCEPTUAL FRAMEWORK; DEVICE THERAPY; DISEASE CLASSIFICATION; HEALTH CARE NEED; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; INVASIVE PROCEDURE; KIDNEY NERVE; PATIENT SAFETY; RENOVASCULAR HYPERTENSION; THERAPY EFFECT;

ANTIHYPERTENSIVE AGENTS; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; DRUG RESISTANCE; HUMANS; HYPERTENSION; PACEMAKER, ARTIFICIAL; TREATMENT FAILURE;

EID: 79551514331     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0156-z     Document Type: Article

References (48)

1. K Heusser J Tank S Engeli, et al. 2010 Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients Hypertension 55 619 626 1:CAS:528:DC%2BC3cXitVKku7k%3D 10.1161/HYPERTENSIONAHA.109.140665 20101001 This study reports data showing decreases in blood pressure, heart rate, and sympathetic nerve activity following acute activation of a chronically implanted carotid baroreceptor pacemaker in 12 patients with drug-resistant hypertension
2. KA Illig M Levy L Sanchez, et al. 2006 An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial J Vasc Surg 44 1213 1218 10.1016/j.jvs.2006.08.024 17145423 (Pubitemid 44828412)
3. MG Mohaupt J Schmidli FC Luft 2007 Management of uncontrollable hypertension with a carotid sinus stimulation device Hypertension 50 825 828 1:CAS:528:DC%2BD2sXhtFGjur%2FN 10.1161/HYPERTENSIONAHA.107.099416 17893424 (Pubitemid 350287517)
4. JH Tordoir I Scheffers J Schmidli, et al. 2007 An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension Eur J Vasc Endovasc Surg 33 414 421 1:STN:280: DC%2BD2s7ksFGrsA%3D%3D 10.1016/j.ejvs.2006.11.025 17227715 (Pubitemid 46336600)
5. K Wustmann JP Kucera I Scheffers, et al. 2009 Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension Hypertension 54 530 536 1:CAS:528:DC%2BD1MXpslektrc%3D 10.1161/HYPERTENSIONAHA.109.134023 19620513
6. H Krum M Schlaich R Whitbourn, et al. 2009 Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 1275 1281 10.1016/S0140-6736(09) 60566-3 19332353 This study reports initial safety and efficacy data from a phase 1 trial investigating blood pressure decreases following RF catheter ablation of the renal nerves. The study reports 3-month follow-up data in 39 patients and 12-month follow-up data in nine patients being treated for drug-resistant hypertension
7. MP Schlaich PA Sobotka H Krum, et al. 2009 Renal sympathetic-nerve ablation for uncontrolled hypertension N Engl J Med 361 932 934 1:CAS:528:DC%2BD1MXhtVKhtbrL 10.1056/NEJMc0904179 19710497 This case-report study presents 3-month and 12-month follow-up data on decreases in blood pressure, renin secretion, NE spillover, and sympathetic nerve activity following RF catheter ablation of the renal nerves in a 59-year-old male with drug-resistant hypertension
8. GF Dibona M Esler 2010 Translational medicine: the antihypertensive effect of renal denervation Am J Physiol Regul Integr Comp Physiol 298 R245 R253 1:CAS:528:DC%2BC3cXhvVyksrs%3D 19955493
9. M Doumas C Faselis V Papademetriou 2010 Renal sympathetic denervation and systemic hypertension Am J Cardiol 105 570 576 10.1016/j.amjcard.2009.10.027 20152255
10. G Mancia G Parati A Zanchetti 2010 Electrical carotid baroreceptor stimulation in resistant hypertension Hypertension 55 607 609 1:CAS:528:DC%2BC3cXitVKkurc%3D 10.1161/HYPERTENSIONAHA.109.147306 20100993
11. MP Schlaich PA Sobotka H Krum, et al. 2009 Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept Hypertension 54 1195 1201 1:CAS:528:DC%2BD1MXhtl2qurrM 10.1161/HYPERTENSIONAHA. 109.138610 19822798
12. MP Schlaich H Krum PA Sobotka 2010 Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension Curr Hypertens Rep 12 39 46 10.1007/s11906-009-0078-6 20425157
13. VM Campese E Kogosov 1995 Renal afferent denervation prevents hypertension in rats with chronic renal failure Hypertension 25 878 882 1:STN:280:DyaK2M3jvVSjsw%3D%3D 7721447
14. UC Kopp SY Jones GF Dibona 2008 Afferent renal denervation impairs baroreflex control of efferent renal sympathetic nerve activity Am J Physiol Regul Integr Comp Physiol 295 R1882 R1890 1:CAS:528:DC%2BD1cXhsFSntbbL 18945951
15. IH Zucker JF Hackley KG Cornish, et al. 2007 Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure Hypertension 50 904 910 1:CAS:528:DC%2BD2sXhtFGjtbfO 10.1161/HYPERTENSIONAHA. 107.095216 17846349 (Pubitemid 350287533)
16. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000, 283:1967-1975.
17. Diuretic versus alpha-blocker as first-step antihypertensive therapy 2003 final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Hypertension 42 239 246 10.1161/01.HYP.0000086521. 95630.5A (Pubitemid 37093467)
18. WC Cushman 2003 Are there benefits to specific antihypertensive drug therapy? Am J Hypertens 16 31S 35S 10.1016/j.amjhyper.2003.07.004 14625158
19. S Bangalore G Kamalakkannan FH Messerli 2007 Beta-blockers: no longer an option for uncomplicated hypertension Curr Cardiol Rep 9 441 446 10.1007/BF02938387 17999868
20. LH Lindholm B Carlberg O Samuelsson 2005 Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis Lancet 366 1545 1553 1:CAS:528:DC%2BD2MXhtFKhsbfI 10.1016/S0140-6736(05)67573-3 16257341 (Pubitemid 41540112)
21. M Esler G Jennings B Biviano, et al. 1986 Mechanism of elevated plasma noradrenaline in the course of essential hypertension J Cardiovasc Pharmacol 8 Suppl 5 S39 S43 10.1097/00005344-198608005-00008 2427882
22. MP Schlaich E Lambert DM Kaye, et al. 2004 Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation Hypertension 43 169 175 1:CAS:528:DC%2BD2cXlvFegsg%3D%3D 10.1161/01.HYP.0000103160.35395.9E 14610101 (Pubitemid 38174169)
23. PG Guyenet 2006 The sympathetic control of blood pressure Nat Rev Neurosci 7 335 346 1:CAS:528:DC%2BD28Xks1OjtLg%3D 10.1038/nrn1902 16760914
24. S Julius L Krause NJ Schork, et al. 1991 Hyperkinetic borderline hypertension in Tecumseh, Michigan J Hypertens 9 77 84 1:STN:280: DyaK3M7mtF2gsw%3D%3D 1848264
25. MP Schlaich DM Kaye E Lambert, et al. 2003 Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy Circulation 108 560 565 10.1161/01.CIR.0000081775.72651.B6 12847071 (Pubitemid 36961170)
26. MP Schlaich DM Kaye E Lambert, et al. 2005 Angiotensin II and norepinephrine release: interaction and effects on the heart J Hypertens 23 1077 1082 1:CAS:528:DC%2BD2MXjt1KmsL4%3D 10.1097/01.hjh.0000166850.80344.cf 15834295
27. M Esler M Rumantir G Wiesner, et al. 2001 Sympathetic nervous system and insulin resistance: from obesity to diabetes Am J Hypertens 14 304S 309S 1:CAS:528:DC%2BD3MXovFOlsLc%3D 10.1016/S0895-7061(01)02236-1 11721888
28. RG Victor MM Shafiq 2008 Sympathetic neural mechanisms in human hypertension Curr Hypertens Rep 10 241 247 1:CAS:528:DC%2BD1cXotVantbw%3D 10.1007/s11906-008-0045-7 18765097
29. SE Epstein GD Beiser RE Goldstein, et al. 1969 Circulatory effects of electrical stimulation of the carotid sinus nerves in man Circulation 40 269 276 1:STN:280:DyaF1M3ovFerug%3D%3D 5810886
30. DW Richter W Keck H Seller 1970 The course of inhibition of sympathetic activity during various patterns of carotid sinus nerve stimulation Pflugers Arch 317 110 123 1:STN:280:DyaE3c3lsFemtA%3D%3D 10.1007/BF00592496 5464986
31. Welcome to CVRx, Inc. Available at http://www.cvrx.com. Accessed June 2010.
32. DA Calhoun D Jones S Textor, et al. 2008 Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 51 1403 1419 1:CAS:528:DC%2BD1cXlvFaitLw%3D 10.1161/HYPERTENSIONAHA.108.189141 18391085
33. IJM Scheffers AA Kroon J Schmidli, et al. 2010 Novel baroreflex activation therapy in resistant hypertension J Am Coll Cardiol 56 1254 1258 10.1016/j.jacc.2010.03.089 20883933 This study presents 3-month, 1-year, and 2-year follow-up data from the DEBuT-HT trial showing decreases in blood pressure following activation of a chronically implanted carotid baroreceptor pacemaker in 45 patients with drug-resistant hypertension
34. Georgakopoulos D, Little WC, Abraham WT, et al. Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction. J Cardiac Fail 2010. doi: 10.1016/j.cardfail.2010.09.004.
35. JS Sanders DW Ferguson AL Mark 1988 Arterial baroreflex control of sympathetic nerve activity during elevation of blood pressure in normal man: dominance of aortic baroreflexes Circulation 77 279 288 1:STN:280: DyaL1c7gvFykug%3D%3D 3338124
36. M Esler 2000 The sympathetic system and hypertension Am J Hypertens 13 99S 105S 1:CAS:528:DC%2BD3cXltlOgurc%3D 10.1016/S0895-7061(00)00225-9 10921528
37. G Grassi G Seravalle F Quarti-Trevano, et al. 2009 Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction Hypertension 53 205 209 1:CAS:528:DC%2BD1MXksl2htA%3D%3D 10.1161/HYPERTENSIONAHA.108.121467 19124679
38. G Mancia G Grassi G Parati, et al. 1997 The sympathetic nervous system in human hypertension Acta Physiol Scand Suppl 640 117 121 1:STN:280: DyaK1c%2FmsFWnsQ%3D%3D 9401621
39. GF Dibona 2005 Physiology in perspective: The Wisdom of the Body. Neural control of the kidney Am J Physiol Regul Integr Comp Physiol 289 R633 R641 1:CAS:528:DC%2BD2MXhtVWktrrI 16105818
40. UC Kopp RL Buckley-Bleiler 1989 Impaired renorenal reflexes in two-kidney, one clip hypertensive rats Hypertension 14 445 452 1:STN:280:DyaK3c%2FgslKlsQ%3D%3D 2793217
41. GF Dibona UC Kopp 1997 Neural control of renal function Physiol Rev 77 75 197 1:CAS:528:DyaK2sXhvVeqsrc%3D 9016301
42. RE Katholi PL Whitlow GR Hageman, et al. 1984 Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog J Hypertens 2 349 359 1:CAS:528:DyaL2cXmt1OqtLc%3D 6397533
43. M Ryuzaki LK Stahl T Lyson, et al. 1997 Sympathoexcitatory response to cyclosporin A and baroreflex resetting Hypertension 29 576 582 1:CAS:528:DyaK2sXhsFeltbo%3D 9040441
44. IH Klein G Ligtenberg PL Oey, et al. 2001 Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension J Am Soc Nephrol 12 2427 2433 1:CAS:528:DC%2BD3MXotl2ls74%3D 11675419
45. IH Klein G Ligtenberg J Neumann, et al. 2003 Sympathetic nerve activity is inappropriately increased in chronic renal disease J Am Soc Nephrol 14 3239 3244 10.1097/01.ASN.0000098687.01005.A5 14638922 (Pubitemid 37509299)
46. DM Morrissey VS Brookes WT Cooke 1953 Sympathectomy in the treatment of hypertension; review of 122 cases Lancet 1 403 408 1:STN:280: DyaG3s%2FkvVKquw%3D%3D 10.1016/S0140-6736(53)91589-X 13024041
47. Ardian, Inc. http://www.ardian.com/medical-professionals/system.shtml. Accessed June 2010.
48. JW Osborn GD Fink 2010 Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat Exp Physiol 95 61 68 1:CAS:528:DC%2BC3cXislWhsrg%3D 10.1113/expphysiol.2008.046326 19717492